Artelo Biosciences (NASDAQ:ARTL) Stock Makes a Bullish Move: Here is Why

November 4, 2021

Artelo Biosciences (NASDAQ:ARTL) has been in the thick of action in recent days and the company’s stock has managed to generate gains of as much as 45% over the course of the past week. Trading Data On Wednesday, ARTL stock increased 3.01% at $1.0300 with more than 20.37 million shares, compared to its average volume of 5.19 million shares. The stock has moved within a range of $0.8745 – 1.0700…

Read More >>

NASDAQ Momentum List: ARTL, NXTP, ALNA, NAKD, ESSCR

November 4, 2021

Following were the most active stock buzzers on Wednesday. Keep an eye on these stocks this week. Artelo Biosciences Inc (NASDAQ:ARTL) stock continued to gain momentum in the previous trading session. The stock went up by 3% to $1.03 with more than 20.37 million shares traded hands, well above its average volume of 4.98 million shares. The stock has soared 44% over the past week and up another 14% in…

Read More >>

Artelo Biosciences Inc (NASDAQ:ARTL) Stock Suddenly Jumps 20% On High Volume

November 2, 2021

This morning, it is quite likely that plenty of investors are going to look into the Artelo Biosciences Inc (NASDAQ:ARTL) stock quite closely. The Artelo stock emerged as one of the notable gainers yesterday and ended the day with gains of as much as 20%. Trading Data On Monday, ARTL stock increased 21.58% at $0.8700 with more than 252.59 million shares, compared to its average volume of 4.14 million shares….

Read More >>

NASDAQ Momentum List: ARTL, ZSAN, SRGA, CSCW, LMNL

November 2, 2021

Following were the most active stock buzzers on Monday. Keep an eye on these stocks this week. Zosano Pharma Corporation (NASDAQ:ZSAN) stock continued to gain momentum in the previous trading session. The stock went up by 16% to $0.70 with more than 23.51 million shares traded hands, well above its average volume of 1 million shares. There’s no specific news from Zosano Pharma stock today that’s behind the climb in…

Read More >>

Where is Artelo Biosciences Inc (NASDAQ: ARTL) Heading?

July 12, 2021

Artelo Biosciences Inc (NASDAQ: ARTL), the clinical-stage biopharmaceutical company, had recently reported its financial results for the Q2-2021 for the duration ending on February 28, 2021. The company’s net income is reported at 36.19%, down from a year before $1.87 million. The company’s cash on hand increased 440.03% on a year-over-year basis at $10.71 million. The headquarters of the company is in California, United States. There has been a 338.32%…

Read More >>